These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31220373)

  • 1. Association of psoriasis/psoriatic arthritis with inflammatory bowel disease influences management strategy.
    Shaw CA; Kole LCS; Elewski BE
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e431-e432. PubMed ID: 31220373
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.
    Pugliese D; Daperno M; Fiorino G; Savarino E; Mosso E; Biancone L; Testa A; Sarpi L; Cappello M; Bodini G; Caprioli F; Festa S; Laino G; Maconi G; Mazzuoli S; Mocci G; Sartini A; D'Amore A; Alivernini S; Gremese E; Armuzzi A
    Dig Liver Dis; 2019 Jul; 51(7):972-977. PubMed ID: 30992173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis.
    Mrowietz U; Riedl E; Winkler S; Xu W; Patel H; Agada N; Lebwohl MG
    J Am Acad Dermatol; 2020 Nov; 83(5):1436-1439. PubMed ID: 32526319
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation.
    Whitlock SM; Enos CW; Armstrong AW; Gottlieb A; Langley RG; Lebwohl M; Merola JF; Ryan C; Siegel MP; Weinberg JM; Wu JJ; Van Voorhees AS
    J Am Acad Dermatol; 2018 Feb; 78(2):383-394. PubMed ID: 29332708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.
    Gniadecki R; Bang B; Sand C
    Br J Dermatol; 2016 May; 174(5):1145-6. PubMed ID: 26522308
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of remission in biologic-naive, severe psoriasis and PsA with dual anti-cytokine combination.
    Haberman RH; Castillo R; Scher JU
    Rheumatology (Oxford); 2021 Jul; 60(7):e225-e226. PubMed ID: 33369644
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.
    Mugheddu C; Atzori L; Del Piano M; Lappi A; Pau M; Murgia S; Zucca I; Rongioletti F
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28833973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ustekinumab associated with flares of psoriatic arthritis.
    Stamell EF; Kutner A; Viola K; Cohen SR
    JAMA Dermatol; 2013 Dec; 149(12):1410-3. PubMed ID: 24132520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N; Yalcin B; Sallahoglu K; Rezvani A
    Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract]   [Full Text] [Related]  

  • 10. Ustekinumab Improves Paradoxical Enteropathy Associated With Psoriasis Arthritis.
    Urushikubo J; Kawasaki K; Eizuka M; Yanai S; Nakamura S; Sugai T; Matsumoto T
    Inflamm Bowel Dis; 2019 Sep; 25(10):e128-e129. PubMed ID: 31300828
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice.
    Almirall M; Rodriguez J; Mateo L; Carrascosa JM; Notario J; Gallardo F
    Clin Rheumatol; 2017 Feb; 36(2):439-443. PubMed ID: 27817126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of ustekinumab in the treatment of psoriatic arthritis.
    Roberts J; O'Rielly DD; Rahman P
    Immunotherapy; 2018 Apr; 10(5):361-372. PubMed ID: 29439608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke under treatment with ustekinumab for psoriatic arthritis.
    Aboudiab M; Andréjak M; Husein T; Goëb V
    Rev Neurol (Paris); 2019 Apr; 175(4):271-272. PubMed ID: 30638925
    [No Abstract]   [Full Text] [Related]  

  • 14. The safety of ustekinumab for the treatment of psoriatic arthritis.
    López-Ferrer A; Laiz A; Puig L
    Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ustekinumab for psoriatic arthritis.
    Cuchacovich RS; Espinoza LR
    Lancet; 2009 Feb; 373(9664):605-6. PubMed ID: 19217153
    [No Abstract]   [Full Text] [Related]  

  • 16. Refractory Palmoplantar Pustular Psoriasis Treated With High-Dose Ustekinumab After Initial Failure.
    Bohdanowicz M; Sajic D
    J Cutan Med Surg; 2019; 23(1):102-104. PubMed ID: 30141337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis.
    Jacobi A; Rustenbach SJ; Augustin M
    Int J Dermatol; 2016 Mar; 55(3):296-302. PubMed ID: 26470689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis: A molecular insight.
    Nguyen CT; Bloch Y; Składanowska K; Savvides SN; Adamopoulos IE
    Clin Immunol; 2019 Sep; 206():15-22. PubMed ID: 30196070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of psoriasis and psoriatic arthritis with secukinumab after unsatisfactory response to ustekinumab in multiple sclerosis patient.
    Assefa GT; Kaneko S; Oguro H; Morita E
    J Dermatol; 2019 Mar; 46(3):e112-e113. PubMed ID: 30151838
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
    Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
    Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.